Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (36)
COVID-19 (13)
Type
Type
Guidance (2013)
NICE advice (319)
Quality standard (197)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (229)
COVID-19 rapid guidelines (8)
HealthTech guidance (765)
Highly specialised technologies guidance (30)
Medicines practice guidelines (5)
NICE guidelines (335)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (881)
Advice programme
Advice programme
Evidence summaries (67)
Medtech innovation briefings (250)
NICE reviews (2)
Apply filters
Showing 1071 to 1080 of 2529
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Icare rebound tonometer to measure intraocular pressure
MIB57
15 March 2016
15 March 2016
icobrain ms for active relapsing–remitting multiple sclerosis
MIB291
29 March 2022
29 March 2022
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides
TA805
13 July 2022
13 July 2022
Idebenone for treating visual impairment in Leber's hereditary optic neuropathy in people 12 years and over
TA1093
28 August 2025
28 August 2025
Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal)
TA936
30 November 2023
30 November 2023
Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 to 4 treatments (terminated appraisal)
TA1084
23 July 2025
23 July 2025
Idelalisib for treating chronic lymphocytic leukaemia
TA359
28 October 2015
28 October 2015
Idelalisib for treating refractory follicular lymphoma
TA604
2 October 2019
2 October 2019
Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal)
TA469
23 August 2017
23 August 2017
Idiopathic pulmonary fibrosis in adults
QS79
29 January 2015
29 January 2015
Previous page
1
…
106
107
Current page
108
109
110
…
253
Page
108
of
253
Next page
Results per page
10
25
50
All
Back to top